Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Methylprednisolone effect on u-AQP-2 in fasting healthy humans
NCT00281710Phase 4Completed
- Sponsor
- Regionshospitalet Holstebro
- Start
- Oct 2005
- Primary completion
- Feb 2007
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 4, single-arm trial of methylprednisolone, sponsored by Regionshospitalet Holstebro. Primary endpoints: Urinary Aquaporin 2 and Fractional Excretion of Sodium. Started Oct 2005; status: completed.
02
Drugs
methylprednisolone
Beyond the preview
Go deeper on NCT00281710.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00281710.